NCT05677126View on ClinicalTrials.gov

Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

August 26, 2024

Conditions
Manganese Safety in Pediatric Patients
Interventions
DRUG

Tralement

Tralement with Manganese

DRUG

Fixed-dose trace element combination product of zinc, copper, and selenious acid

Tralement without Manganese

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY

NCT05677126 - Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN | Biotech Hunter | Biotech Hunter